Skip to main content
Premium Trial:

Request an Annual Quote

In Brief This Week: GE Healthcare; BioServe; DNA Genotek

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – GE Healthcare has opened a new medical technology manufacturing facility in Cardiff, Wales. The $15 million facility will produce nearly 2,000 life sciences products used in the pharmaceutical, food, and environmental industries. GE said that it already employs more than 400 people at the facility.


BioServe said this week that it has received accreditation from India's National Board of Testing and Calibration of Laboratories for detecting genetically modified materials in raw and processed foods. The firm announced the accreditation in conjunction with the launch of a line of PCR-based tests for detecting genetically modified organisms.


DNA Genotek said that the South African Tuberculosis Vaccine Initiative has chosen to use the firm's Oragene DNA Self-Collection Kits to obtain samples for a study aimed at identifying host correlates of protection against TB, following BCG vaccination.

The Scan

Self-Reported Hearing Loss in Older Adults Begins Very Early in Life, Study Says

A JAMA Otolaryngology — Head & Neck Surgery study says polygenic risk scores associated with hearing loss in older adults is also associated with hearing decline in younger groups.

Genome-Wide Analysis Sheds Light on Genetics of ADHD

A genome-wide association study meta-analysis of attention-deficit hyperactivity disorder appearing in Nature Genetics links 76 genes to risk of having the disorder.

MicroRNA Cotargeting Linked to Lupus

A mouse-based study appearing in BMC Biology implicates two microRNAs with overlapping target sites in lupus.

Enzyme Involved in Lipid Metabolism Linked to Mutational Signatures

In Nature Genetics, a Wellcome Sanger Institute-led team found that APOBEC1 may contribute to the development of the SBS2 and SBS13 mutational signatures in the small intestine.